A 5-day treatment with the potent rexinoid LG268 altered myeloid and T-cell populations in the tumor microenvironment of MMTV-Neu mice and significantly (p = 0.002) increased the expression of PD-L1. This evidence concerns the gene ERBB2 and neoplasm.